CS logo
small CS logo
Kursk Regional Oncology Centre

Kursk, Russian Federation
Cancer treatment center in Russia
х, Елисеева, 1, Kislino, Kursk Oblast, 305016

About Kursk Regional Oncology Centre


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Nektar Therapeutics
2
Jounce Therapeutics, Inc.
1
Morphotek
1
Mylan Pharmaceuticals Inc
1
Total Rows: 4

Clinical Trials at Kursk Regional Oncology Centre


During the past decade, Kursk Regional Oncology Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111002200000000Started TrialsCompleted Trails20172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)
2018-12-18
2022-10-19
Terminated
623
Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence
2020-07-27
2022-09-22
Terminated
765
Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen
2020-10-19
2023-03-01
Active, not recruiting
75
MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC
2017-01-21
2019-11-22
Completed
671

Rows per page:

1–5 of 5

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kursk Regional Oncology Centre" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator and "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNektar Therapeutics: 2Nektar Therapeutics: 2Jounce Therapeutics, Inc.: 1Jounce Therapeutics, Inc.: 1Morphotek: 1Morphotek: 1Mylan Pharmaceuticals Inc: 1Mylan Pharmaceuticals Inc: 1

Created with Highcharts 11.1.0Top CollaboratorsBristol-Myers Squibb: 2Bristol-Myers Squibb: 2Eisai Europe Ltd.(United Kingdom): 1Eisai Europe Ltd.(United Kingdom): 1

Clinical Trials Conditions at Kursk Regional Oncology Centre


According to Clinical.Site data, the most researched conditions in "Kursk Regional Oncology Centre" are "Melanoma" (1 trials), "Melanoma (Skin)" (1 trials), "Melanoma Stage III" (1 trials), "Melanoma Stage IV" (1 trials) and "Metastatic Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Kursk Regional Oncology Centre" in a lesser frequency.

Clinical Trials Intervention Types at Kursk Regional Oncology Centre


Most popular intervention types in "Kursk Regional Oncology Centre" are "Biological" (3 trials) and "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Bempegaldesleukin" (1 trials), "Bevacizumab as Avastin" (1 trials), "Bevacizumab as MYL-1402O" (1 trials), "Carboplatin" (1 trials) and "Farletuzumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kursk Regional Oncology Centre


The vast majority of trials in "Kursk Regional Oncology Centre" are 4 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Kursk Regional Oncology Centre


Currently, there are NaN active trials in "Kursk Regional Oncology Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kursk Regional Oncology Centre, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Kursk Regional Oncology Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusTerminated: 3Terminated: 3Active, not recruiting: 1Active, not recruiting: 1Completed: 1Completed: 1